Guru P. Sonpavde/adventhealthcancerinstitute.com
Dec 8, 2024, 06:29
Guru P. Sonpavde: Year in Review 2024 – Bladder Cancer
Guru P. Sonpavde, GU Oncology Director at Advent Health Cancer Institute, shared a post on X:
“Bladder Cancer 2024- Honored to review highlights of the year.”
Video attached to the post.
Dr. Guru Sonpavde is the Oncology and Phase I Clinical Trials Director at AdventHealth Central Florida and the Chair of Bladder Cancer Research. He is also a Professor of Medicine at the University of Central Florida. His primary focus is drug development, leading innovative clinical trials on novel immunotherapies and targeted therapies for genitourinary cancers, especially bladder cancer, along with prostate, kidney, penile, and testicular cancers.
More posts featuring Guru P. Sonpavde.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 25, 2025, 17:30
May 25, 2025, 17:10
May 25, 2025, 17:02
May 25, 2025, 16:51